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1. Introduction 
 
Sugar-nucleotides (sugar-nucleoside diphosphates) are imperative to carbohydrate 
metabolism and glycoconjugate biosynthesis. They are composed of an activated sugar donor 
that is glycosylated onto a diverse range of acceptors, typified by glycosyltransferase catalysed 
processes for the assembly of glycosides1 and oligo- or polysaccharides.2 They are of 
considerable interest as carbohydrate-based tools for the study of glycoconjugate biosynthesis 
and for their potential as enzyme inhibitors in new therapeutic strategies.3 In addition, they are 
important for unambiguous biochemical assay development and for the provision of 
structurally defined homogenous analytical standards. We recently reviewed the current start 
of the art (2009 onwards) regarding chemical approaches to synthesise sugar-nucleotides and 
present here a complimentary appraisal of the enzymatic methods that have emerged during 
the same period.  
 
1.1. Enzymatic approaches towards sugar-nucleotides 
 
Sugar-nucleotides are structurally diverse, consisting of a sugar linked to a nucleoside 
diphosphate (sugar nucleoside monophosphates, such as CMP-sialic acid, are not covered 
here). Figure 1a illustrates a generic sugar-nucleotide, alongside the common enzymatic 
strategies that have been used for their synthesis, starting from the hemi-acetal. The advent of 
one-pot multi-enzyme (OPME) approaches to complex carbohydrates4 has meant that access 
to sugar-nucleotides and the glycosyltransferases (GTs) that utilise them is much simplified 
compared to classic synthetic chemistry methods. From the perspective of the promiscuity of 
the enzymes involved, there is still development required to access diverse/non-native targets 
and, generally speaking, bacterial enzymes have shown greater promise in this regard.  
In animal cells the most commonly occurring sugar-nucleotides utilise a uridine or 
guanidine-containing nucleoside diphosphate (UDP or GDP) along with a sugar; this includes 
aldopentose (UDP-Xyl), aldohexose (UDP-Glc, UDP-Gal, GDP-Man), aldohexosamine 
(UDP-GlcNAc, UDP-GalNAc) and uronic acid (UDP-GlcA) components.5 These common 
mammalian examples are illustrated in Figure 1b), alongside some examples found in bacteria, 
such as GDP-ManA, UDP-Galf and dTDP-Glc.  
We have divided this review into sections, first covering enzymes that are available for 
the provision of glycosyl 1-phosphates, followed by the use of uridylyltransferases for 
nucleoside diphosphate formation. Finally, we consider emergent new strategies such as the 
reversal of GT activity to produce sugar-nucleotides. 
 
 
   
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. a) Enzymatic approach to sugar-nucleotides, using a kinase to access a glycosyl 1-phosphate for 
subsequent reaction with a uridylyltransferase (pyrophosphorylase). The use of pyrophosphorylases and a NTP 
is often combined with a pyrophosphatase to degrade the diphosphate by-product, providing a thermodynamic 
sink to the process b) representative examples of common mammalian and bacterial sugar-nucleotides. PPi = 
pyrophosphate, Pi = phosphate. 
 
 2. Enzymes for the preparation of glycosyl 1-phosphates  
 
In an effort provide access to useful glycosyl 1-phosphates and an economic benefit in 
not having to utilise expensive NTP donors for such processes, Nidetzky and colleagues 
described a two-step diastereoselective phosphorylation of pyranoses (Scheme 1).6 Their 
studies demonstrated an endo-anomeric centre phosphorylation of sucrose by inorganic 
phosphate, catalysed by sucrose phosphorylase (SPase), followed by a selective 
transphosphorylation of the product Glc 1-phosphate with a sugar acceptor and glucose 1-
phosphatase (AGP). This enzyme combination delivered α-configured glycosyl 1-phosphates 
of D-Man, D-Gal and D-GlcNAc in yields between 50 and 70%. The authors also developed a 
useful enzymatic purification procedure whereby the phosphatase (BT4131) was able to 
effectively distinguish between desired anomeric and unwanted 6-position phosphates, thereby 
hydrolysing any side reaction that produced 6-phosphates. This method produced up to 40 mg 
from a single small-scale reaction and demonstrated that AGP is capable of 
transphosphorylation to a broad range of acceptors, using Glc 1-phosphate as a substrate. 
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Scheme 1. Synthesis of glycosyl phosphates using SPase from Leuconostoc mesenteroides and AGP from E. coli 
in a combination catalyst system. BT4131 from Bacteroides thetaiotaomicron. 
 
In 2018 the Flitsch group described the production and utilisation of a new bacterial 
galactokinase, LgGalK, which produced Gal 1-phosphate with a conversion rate of 72% 
(Scheme 2a).7 Crucially, the enzyme also exhibited a broad substrate tolerance, as evidenced 
by the  synthesis of a range of Gal 1-phosphate analogues, including deoxy and deoxy-fluoro 
substituted systems. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2. a) Synthesis of Gal 1- phosphates by using LgGalK from Leminorella grimontii b) Use of LgGalK for 
a one-pot, two-step access to 6-position modified Gal 1-phosphates. 
 
 LgGalK was also used for a one-pot, two-step strategy towards a series of more 
complex 6-position modified galactose 1-phopshates. Using their galactose oxidase, GOase-
M1, the C6 position was first oxidised to the corresponding aldehyde, followed by treatment 
with LgGal to the 1-phosphate and in situ reductive amination to produce a matrix of thirty 6-
position amino Gal-1-phosphate derivatives, confirmed by HRMS analysis (Scheme 2b). This 
modification strategy could also be used with 2-deoxy-2-fluoro Gal as the starting hexose, 
further extending the matrix of products and providing a powerful approach to deliver modified 
glycosyl 1-phosphate chemical tools. 
Since 2009 several other kinases have been utilised to access a range of glycosyl 1-
phosphates, however, as these were generally combined within multi-enzyme approaches 
towards sugar-nucleotides, we have discussed these inclusively in the following sections. 
 
 
 
 
LgGalK O
OH
HO
HO
HO
O P
O
O
O
O
OH
HO
HO
HO
OH
P
O
OHO
O
72%
Broad substrate tolerance
3- and 6-deoxy Gal
GalN 
2-,3-,4- or 6-deoxyfluoro Gal
a)
b)
GOase-M1
O
NH
HO
HO
HO
O P
O
O
O
O
OH
HO
HO
HO
OH
LgGalK
R-NH2
NaCNBH3
R = broad range or alkyl, 
aryl, cycloalkyl substituents
R
OH
O
OH
HO
HO
HO
O O
OH
OH
HO
P
O
OHO
O
SPase
O
OH
HO
HO
HO
O P
O
O
O
+ D-Fru
O
OH
OH
HO
AGP
O
OH
HO
O P
O
O
O
D-Man
D-Gal
D-GlcNAc
50-70%
D-Man 1-P
D-Gal 1-P
D-GlcNAc 1-P
O
OPO3
2
HO
OH
BT4131
Side-product removal
Hexose
3. Enzymes for the pyrophosphorylation of sugar 1-phosphates  
 
3.1. Towards UDP and dTDP sugar-nucleotides 
 
In 2015, Field et al. reported a one-pot multienzyme approach to base modified UDP-
Glc and UDP-Gal (Scheme 3).8 This provided enzymatic access to a new class of 5-position 
modified sugar-nucleotides, which had previously demonstrated promise as GT inhibitors9 and 
as fluorescent tools for GT assay development.10 Their strategy employed a small panel of 5-
position modified UTPs and Glc 1-phosphate, incubated with UDP-glucose pyrophosphorylase 
(GalU) to generate, in situ, a modified UDP-Glc in catalytic quantity, to be continuously 
recycled by GalU. Subsequently, Gal 1-phosphate uridylyltransferase (GalPUT) catalysed the 
reaction of base-modified UDP-Glc into Glc 1-phosphate and the corresponding UDP-Gal.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3. Enzymatic preparation of base-modified UDP-Glc and UDP-Gal. GalPUT = galactose-1-phosphate 
uridylyltransferase from E. coli. GalU = UDP-glucose pyrophosphorylase from E. coli. EaGalE  from Erwinia 
amylovora. IPP = pyrophosphatase. 
 
Reaction of these enzymes with 5-substituted UTPs was slower in comparison to the 
parent UTP, but furnished 5-substituted UDP-Gal derivatives 1 (5%), 2 (23%) and 3 (<5%), 
albeit in lower yields than the wild-type. For 5-iodo- and 5-(5-formyl-2-thienyl)-UTP no 
product (4 or 5) was observed. A series of reverse reactions and inhibition experiments led to 
the conclusion that GalPUT was the limiting factor in this one-pot system. Furthermore, there 
was an observed degree of relaxed specificity towards the nucleotide triphosphate component 
using GalU, which was able to independently convert all the UTP analogues to UDP-Glc 
derivatives. Finally, a 4’’-epimerase was used to independently convert 5-iodo UDP-Glc into 
4, achieving a ca 7.5:2.5 equilibrium ratio of Glc/Gal after 30 mins.  
This strategy was also used by the group for an enzymatic synthesis of 6-deoxy 6-
fluoro-UDP-Glc.11 Starting from Gal, GalK, GalPUT and GalE were used to deliver the 6-
deoxy 6-fluoro sugar-nucleotide and, coupled with an expedient purification method, 
demonstrated a capability to provide 19F radio-labelled sugar-nucleotide derivatives. Lowary 
and co-workers also utilised a three-enzyme system, containing GalPUT, GalU and a 
O
N
OHOH
OP
O
OP
O
O
O O
NH
O
O
X
P
O
O
O
O
O
N
OHOH
OP
O
OP
O
O
O O
NH
O
O
X
OH
HO
HO
HO
GalU
PPi
IPP
2 Pi
O
OH
HO
HO
HO
O P
O
O
OGlc-1-P
UDP-Glc
GalPUT
O
OH
HO
HO
O P
O
O
OGal-1-P
HO
O
O
N
OHOH
OP
O
OP
O
O
O O
NH
O
X
OH
HO
HO
HO
UDP-Gal
+
X =
OMe
O
X-UTP
+
S
O
+
ca db e
X = I, substrate 
for EaGalEOne-pot 
multi-enzyme 
system
+
I
O
X = a = 1, X = b = 2, X = c = 3,
X = d = 4, X = e = 5
phosphatase for their enzymatic synthesis of native and modified UDP-Galf derivatives.12 
Whilst deoxy modified 1-phosphates (3-, 5- and 6-positions) were substrates for the system, 
OMe capping of hydroxy groups (at positions 2, 5 and 6) was not tolerated. The group also 
recently showed that GalPUT was unable to produce UDP-GalfNAc, UDP-GalfN3 or UDP-
GalfNH2, confirming the sensitivity of this nucleotidyltransferase to the nature of the C2 
group.13 
The Chen group have made several important contributions to access sugar-nucleotides 
using enzymatic approaches14 and most recently the group developed a OPME for the synthesis 
of UDP-uronic acids (Scheme 4).15 Notably, this avoided the more expensive use of an NAD+ 
dependant oxidative uronyl dehydrogenase to access UDP-GlcA.16 The workers evaluated a 
bacterial glucuronokinase (AtGlcAK) and demonstrated its capability to accept GlcA, GalA 
and ManA substrates with good conversion to the desired uronate 1-phosphates in quantitative, 
31% and 95% yields respectively. A galactokinase (BiGalK) also showed activity here for just 
GalA, however evaluations for L-IdoA showed it was not a substrate for either kinase.  
Accordingly, their sugar 1-phosphates were evaluated as substrates for two UDP-sugar 
pyrophosphorylases, BLUSP and AtUSP. BLUSP delivered UDP-GlcA in 80% yield, , but did 
not produce UDP-GalA. Comparatively, AtUSP delivered UDP-GlcA in a lower yield of 57%, 
but was shown to work in accessing UDP-GalA (39% yield) and neither enzyme was able to 
produce GDP-ManA. This OPME approach was subsequently harnessed within a sequential 
process for the synthesis of heparosan oligosaccharides. 
 
 
 
 
 
 
 
 
 
Scheme 4. One-pot three-enzyme synthetic approach to UDP-GlcA and UDP-GalA. AtGlcAK from Arabidopsis 
thaliana, BLUSP from Bifidobacterium longum, AtUSP (from Arabidopsis thaliana). *not from BLUSP 
 
AtUSP has also been used by Wong et al. to produce UDP-Gal in their large-scale 
synthesis of cancer associated antigens Globo H and SSEA4.17 The group focused on salvage 
pathway enzymes to successfully regenerate the required sugar-nucleotides. Alongside AtUSP, 
GlmU (for regeneration of UDP-GalNAc) and FKP, a bifunctional enzyme found in 
Bacteroides with L-fucose-1-phosphate guanyltransferase and L -fucose kinase activities, all 
showed capability for a powerful in situ nucleoside diphosphate regeneration strategy. 
UDP-galactopyranose mutase (UGM) plays a key role in the cell wall biosynthesis of 
many pathogenic microorganisms, including Mycobacterium tuberculosis, catalysing a 
reversible isomerization of UDP-Galp to UDP-Galf. The absence of Galf in humans makes 
UGM a potential target for developing novel antibacterial agents and, as such, there is a need 
for sugar-nucleotide tools to study the associated chemical and structural biology. The 
phosphonate analogue of UDP-Galp, UDP-phosphono-galactopyranose (UDP-CH2-Galp) had 
previously been proposed and synthesised as a probe for deciphering the UGM mechanism.18 
Seeking to improve upon prior chemical syntheses of UDP-CH2-Galp where side reactions and 
decomposition following the key chemical pyrophosphorylation were observed, Sanders and 
co-workers described a novel chemoenzymatic synthesis of UDP-CH2-Galp.
19 Starting from 
the phosphonate analogue of Gal 1-phosphate and catalysed by recombinant AtUSP (Scheme 
5), their strategy proved successful, delivering 19 mg of the target sugar-nucleotide with an 
isolated, purified yield of 45% (from a recovery of 25% starting Gal 1-phosphonate). The 
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authors noted that recombinant AtUSP was approximately 50-fold less active towards the 
glycosyl 1-phosphonate than native sugar 1-phosphates.  
 
 
 
 
 
Scheme 5. Chemoenzymatic synthesis of UDP-CH2-Galp using AtUSP from Arabidopsis thaliana. 
In 2013, a one-pot three-enzyme synthesis of UDP-Glc/Gal and their derivatives was 
reported by Chen and co-workers.20 Using their catalytic system, UDP-Glc and six unnatural 
UDP-Gal derivatives (including UDP-2-deoxy-Gal and UDP-GalN3 were efficiently 
synthesised in a one pot procedure (Scheme 6). Initially, anomeric phosphorylation of Glc/Gal 
by a galactokinase (SpGalK, previously characterised by the group21) afforded Gal/Glc 1-
phosphates which were subsequently pyrophosphorylated by glucose pyrophosphorylase, 
SpGalU. A commercial inorganic pyrophosphatase (PPase) was added to degrade PPi, 
preventing its inhibition of SpGalU. The method was scalable (7 mg of UDP-Glc could be 
produced) and offered access to natural sugar-nucleotides (Gal/Glc/L-Man) and mimetic (seven 
Gal analogues with modifications at C2, C4 and C6) species with variable yields (90% for 
UDP-Gal, 26% for UDP-Glc). 
 
 
 
 
 
Scheme 6. One-pot three-enzyme synthesis of UDP-Glc/Gal and derivatives, SpGalK and SpGalU from 
S. pneumoniae. 
Wang and colleagues described the synthesis of eight UDP-GlcNAc analogues and 
three UDP-GalNAc analogues using a recombinant N-acetylglucosamine 1-phosphate 
uridylyltransferase (GlmU) with moderate yields (10-65%) and on relatively large scales (35-
75 mg).22 During this work the authors noted a narrow substrate specificity for GlmU in 
accepting GalNAc 1-phosphate analogues and duly explored a recombinant human UDP-
GalNAc pyrophosphorylase (AGX1) to enable mimetic sugar-nucleotide synthesis.23A total of 
nine GalNAc 1-phosphate and five GlcNAc 1-phosphate derivatives were prepared 
chemoenzymatically using N-acetylhexosamine 1-kinase (NahK), as previously described by 
the group,24 and then tested using AGX1, which exhibited a good tolerance of NAc and 4- and 
6-position modifications of Gal and Glc (Scheme 7).  
Comparatively, AGX1 was observed to exhibit a broader specificity than GlmU 
towards modified UDP-Glc/Gal targets, although neither enzyme was capable of accepting 4-
position substituents larger than OH. GlmU differentiated Gal/GlcNAc-1-phosphate analogues 
with bigger N-acyl modifications whereas AGX1 was only slightly affected by the bulkiness 
of N-acyl groups in both Gal/GlcNAc systems. Moreover, AGX1 also showed good tolerance 
to C-6 modified 1-phosphate analogues 6-deoxy GalNAc-1-P and 6-azido-GalNAc-1-P. 
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Scheme 7. AGX1 uridylyltransferase to access to UDP-GalNAc/GlcNAc analogues. 
 
Anomeric phosphonates, a mimetic of native glycosyl 1-phosphates, have significant 
potential as metabolically stable glycosyltransferase probes. In 2009, Jakeman et al. reported 
the use of Cps2L in a nucleotidylyltransferase catalysed coupling of dTTP and UTP nucleotides 
with phosphonate analogues of Glc and Gal 1-phosphate (Scheme 8).25 Previous chemical 
synthesis approaches to such analogues had been encumbered by slow reaction times and 
diminished yields.26 
They probed the interaction of phosphonate analogues 6 and 7 with Cps2L to afford the 
desired sugar-nucleotide analogues. Incubation of 6 with dTTP and UTP proceeded with 
conversions of 95% and 70% respectively, but conversion of 7 was significantly lower (40%, 
as adjudged by HPLC analysis). Though the geometric and ionisation state changes between 
phosphate and phosphonate were found to partially account for a decrease in turnover 
efficiency, compared to the physiological substrate, the change in stereochemistry at C4 was 
deemed to have a greater significance on conversion.  
  
 
 
 
 
 
 
 
Scheme 8. Synthesis of dTDP and UDP Glc and Gal phosphonate analogues using Cps2L.  
 
In order to evaluate the effect of -monofluorination in probing Cps2L, Jakeman also 
reported the synthesis of a series of ketose phosphonates (Scheme 9).27 They observed that an 
S-configured -monofluorinated phosphonate was a substrate for Cps2L, showing 100% 
conversion, whilst the diastereomeric R-phosphonate was only converted in 20%. An -gem-
difluoro analogue was not turned over by the enzyme. Their method provided access to 5-10 
mg quantities of the phosphonate sugar-nucleotides in 10-55% yields and the broader results 
of their study provided important insight into the effect of -monofluorination upon 
glycosyltransferase activity, correlating factors of enzyme turnover, ketose mutarotation and 
phosphonate acidity for this class of mimetic sugar-nucleotide.  
 
 
 
 
 
 
 
 
O
OH
OP
O
O
O
HO
HO
HO
HO
P
O
O
O
RR1 O
HO
HO
HO
HO
P
O
O
O
RR1
N
NH
O
O
H3C
OH OH
R = F, R1 = H = 100% conv.
R = H, R1 = F = 20% conv.
R = R1 = F = no conv.
dTDP-Glc phosphonates
Cps2L
dTTP PPi
  
 
 
 
 
Scheme 9. dTDP-ketose phosphonate sugar-nucleotide synthesis catalysed by Cps2L. 
 
The group also reported the first synthesis of a dTDP-Glc-1-thiophosphonate again 
using Cps2L.28 A non-scissile glycosyl thiophosphonate analogue (Scheme 10) was evaluated 
as a Cps2L substrate, forming the desired dTDP-glycosyl thiophosphonate with a 15% 
conversion rate (ESI-MS confirmed that an O-pyrophosphate had formed). Only one peak was 
observed by HPLC for the thiophosphonate product, which inferred that Cps2L may 
distinguish between pro-R and pro-S thiophosphonate oxygen atoms; a similar observation 
having been made for pro-R and pro-S -monofluorinated phosphonate (Scheme 9).  
 
  
 
 
 
 
Scheme 10. Csp2L catalysed synthesis of the first dTDP-Glc-1-thiophosphonate analogue of Glc-1-phosphate. 
 
Most recently the group have extended their investigation of Cps2L promiscuity (and a 
GDP-ManPP) against a panel of eight fluorinated isosteric Glc 1-phosphates, broadly 
reaffirming a defined utility for Cps2L in the advancement of enzymatic synthesis of mimetic 
sugar nucleotides and indicating that the acidity of the phosphate nucleophile and the hexose 
configuration each contribute to substrate specificity.29 The Lowary group also used Cps2L for 
an enzymatic synthesis of dTDP-Galf, obtaining the sugar-nucleotide in 50% yield from Galf 
1-phosphate using Cps2L immobilised on a Ni-NTA agarose resin.12a=12a 
In 2012, Linhardt et al. reported a chemical synthesis of eight different GlcNAc 1-
phosphate and GalNAc 1-phosphate analogues and tested their capability with GlmU (Scheme 
11).30 Substrates containing an amide linkage at C2 were transferred by GlmU to afford their 
corresponding UDP sugar-nucleotides in good yields (50-80%). The studies demonstrated that 
whilst the presence of an amide at C2 was essential (no conversion was observed with GlcN3 
or GlcNH2), the C4 OH did not appear to play a critical role in enzyme substrate recognition 
as UDP-GalNAc was obtained in 70% yield. The group were also able to demonstrate 
immobilisation of GlmU onto Ni Sepharose beads and subsequent sugar-nucleotide formation, 
providing a useful platform to develop a technology for GlmU recycling and its use in 
continuous processes.  
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Scheme 11. Enzymatic synthesis of modified UDP-GlcNAc and UDP-GalNAc using GlmU from E. coli 
Following on from this the group also reported a first chemoenzymatic synthesis of 4’’-
fluorinated UDP-GlcNAc and UDP-GalNAc using GlmU (Scheme 12).31 Synthetically 
prepared 4-fluoro-hexosamine 1-phosphates were accepted by GlmU, providing the 
corresponding UDP-sugar nucleotides in moderate yields (45-50%) and further concluding that 
the configuration of the pyranose 4-OH appeared not to play a critical role for turnover by the 
enzyme.  
 
 
 
 
 
 
 
 
 
 
Scheme 12. Chemoenzymatic synthesis of 8 and 9 using GlmU. 
 
Liu and co-workers have also utilised the promiscuity of GlmU for the provision of 
UDP-GlcNTFA, from GlcNTFA 1-phosphate.32 This has proven to be a powerful sugar-
nucleotide tool for the chemoenzymatic assembly of heparan sulfate glycosaminoglycans, 
offering a unique nitrogen protecting group to effect site specific N-sulfation within the final 
oligosaccharide targets.33 
GlmU from Pasteurella multocida (PmGlmU) has also been used as part of a successful 
cascade process for the development of tools to highlight epigenetic modifications. PmGlmU 
successfully transferred 6-deoxy-6-azido-Glc to UTP which was then used by a 
glucosyltransferase to glycosylate DNA 5-hydroxymethylcytosine residues, affording the 
required ‘6-azide for isolation or fluoro-tagging using click chemistry.34 PmGlmU was also 
used successfully by Chen as part of a OPME system for synthesising a series of UDP-GlcNAc 
derivatives, including modifications to the N- and 6-poistions of Glc, including the 
incorporation of O-sulfate.35 
In 2012, Lin and co-workers reported the synthesis of UDP-Gal using RmIA, a glucose 
1-phosphate thimidylyltransferase used to synthesise TDP-Glc in nature.36 Direct synthesis of 
UDP-Gal was achieved in the presence of wild-type RmIA, with this method proving scalable, 
delivering 100 mg of UDP-Gal in 90% yield (Scheme 13). The group also utilised RmIA for a 
sequential synthesis of a series of sialylated oligo-LacNAcs.37 RmLA was harnessed in a cost 
saving method to synthesise UDP-Gal and UDP-GlcNAc from the corresponding sugar 1-
phosphates in one pot. These sugar-nucleotides were in turn derived from their free sugars 
using the kinases MtGalK (for Gal 1-phosphate) and NahK (for GlcNAc 1-phosphate). UDP-
Gal and UDP-GlcNAc were then used with two bacterial glycosyltransferases to produce 
defined lengths of oligo-LacNAc. Their approach showed a powerful application of a 
thermophilic thymidylyltransferase to effect multiple sugar-nucleotide syntheses in one pot. 
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Scheme 13. Scaled synthesis of UDP-Gal using RmIA from A. thermoaerophilus. 
In Table 1 we summarise the enzymes available for the synthesis of UDP and dTDP 
sugar-nucleotides. There are several plant, bacterial, human and archaeal options, offering 
access to a range of targets and a growing resource of substrate-enzyme SAR for both 
functional group modifications and hexose substrate promiscuity. New enzymes are also 
emerging, typified by a recent report from Routier et al. who described the characterisation of 
a new bacterial UDP-sugar pyrophosphorylase from Leishmania.38 The enzyme displayed a 
close relation to plant UDP-sugar pyrophosphorylases, capable of providing UDP-Gal without 
the Leloir pathway dependence of UDP-Glc and was able to process Gal- and Glc 1-phosphates 
along with other hexose and pentose 1-phosphates, but notably not hexosamine 1-phosphates.  
 
UDP and dTDP Sugar Nucleotides 
Enzyme 
 
Source Target sugar-nucleotide(s) Ref(s). 
GalU E. coli 
 
 
UDP-Glc  
5-position base modified UDP-Glc 
(5-I, 5-furanyl)  
8 
BLUSP B. longum UDP-GlcA 15 
AtUSP A. thaliana 
 
UDP-GlcA 
UDP-GalA 
UDP-Gal 
UDP-CH2-Galp 
15 
15 
17 
19 
SpGalU S. pneumoniae 
 
 
 
UDP-Glc 
UDP-Gal 
UDP- L-Man 
2, 4 and 6 modified UDP-Gal 
20 
AGX1 Human 
 
UDP-GlcNAc 
UDP-GalNAc 
NAc and 6-position modified UDP-
Gal and UDP-Glc 
23 
GalPUT* 
 
 
 
 
GalPUT 
 
E. coli 
 
 
UDP-Gal  
5-position base modified UDP-Gal 
(5-I, 5-furanyl)  
6-deoxy-6-fluoro UDP-Glc 
 
UDP-Galf and 2,5,6-OMe 
modifications 
8 
 
 
11 
 
12 
Cps2L S. pneumoniae 
 
 
 
dTDP-gluco-ketose phosphonates  
dTDP-Glc phosphonate 
UDP-Glc phosphonate 
dTDP-Gal phosphonate 
dTDP-Glc thiophosphonate 
dTDP-Galf 
27 
25 
25 
25 
28 
12a 
GlmU E. coli UDP-4-F-GlcNAc 31 
  
 
 
 
P. multocida 
UDP-4-F-GalNAc 
UDP-GlcNTFA 
UDP-Glc/GalNAc 
N-modifications 
UDP-GalNAc 
UDP-6-deoxy-6-azido-Glc 
UDP-GlcNAc 
N- and 6-position modifications 
  
31 
39 
30 
 
17 
34 
35 
RmIA A. thermoaerophilus 
 
UDP-Gal 
UDP-GlcNAc 
36 
37 
Table 1. Summary of enzymes recently used to synthesise UDP and dTDP sugar-nucleotide targets. 
*with GalE and Galk. 
 
3.2. Towards GDP sugar-nucleotides 
 
Wang and co-workers reported an efficient enzymatic synthesis of GDP sugar-
nucleotides and their derivatives using a one-pot, three enzyme approach, starting from 
monosaccharide hemi-acetals (Scheme 14).39 Glycoside 1-phosphate formation was catalysed 
by N-acetylhexosamine 1-kinase (NahK_15697, previously established by the group as having 
mannose 1-kinase activity40), followed by a GDP-mannose pyrophosphorylase (PFManC), 
forming the required GDP-sugar. Pleasingly, the authors noted that whilst PFManC was known 
to work with ATP (to make ADP-sugars), they were able to use GTP as the sole phosphate 
donor for the combined process. Finally, an inorganic pyrophosphatase (EcPpA) catalysed 
hydrolysis of pyrophosphate. Their approach was demonstrated for a variety of GDP-Man 2-
position analogues, 10-13 (Scheme 13), in high yields and also 4-azido GDP-Man. 
Furthermore, they were able to access a GDP-Glc series along with GDP-Tal, but also 
discovered that NahK_15697 was incompatible with 6-position modified mannose derivatives 
(ManA and 6-deoxy-Tal). Bulkier groups at C2 (NAc) were not accepted by PFManC for either 
Man or Glc 1-phosphates. 
 
 
 
 
 
 
 
 
 
Scheme 14. One-pot three-enzyme synthetic approach to GDP-Man and 2-position derivatives 10-13. 
NahK_15697 from Bifidobacterium infantis, PFManC from Pyrococcus furiosus, EcPpA from E. coli. 
 
In 2012, Lowary reported a chemoenzymatic synthesis of GDP-Man analogues starting 
from a series of chemically modified deoxy and methoxy mannose-1-phosphates (Scheme 
15).41 The group utilised a pyrophosphorylase (GDP-ManPP) and demonstrated that whilst the 
enzyme was able to turnover their modified substrates, it was largely intolerant of methoxy 
substituents at the C2, C3 or C4 positions of mannose, exhibiting 6-, 14- and 17-fold decreases 
in activity respectively. However, 6-methoxy and 6-deoxy-mannose 1-phosphates showed 
relatively good activity (>75%), concluding that the 6-position hydroxyl group may not be 
inherently involved in substrate binding, the inverse of the requirements at C2, C3 and C4. 
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These findings correlated to previous work surrounding the substrate promiscuity of GDP-
ManPP.42 
 
 
 
 
 
Scheme 15. Chemoenzymatic synthesis of GDP-Man analogues to probe the promiscuity of a GDP-ManPP 
from Salmonella enterica. 
In 2009, Pohl et al. reported a first chemoenzymatic synthesis of a range of sugar-
nucleotides using a thermostable bifunctional phosphomannose isomerase/GDP-Man 
pyrophosphorylase (manC).43 Previous work indicated that such archaeal enzymes had broad 
substrate specificity, providing potential for the synthesis of natural and non-natural sugar-
nucleotides, otherwise difficult to access chemically.44 ManC was first investigated for NTP 
tolerance, with results showing that the enzyme was highly permissive, accepting all five 
naturally occurring NTPs in the presence of mannose-1-phosphate; the corresponding NDP-
mannoses were afforded in yields exceeding 80%, with the exception of dTDP-mannose (43%, 
Scheme 16).  
The enzyme also showed relatively high activity against Gal-, Glc-, GlcNH2-, GlcNAc- 
and Fuc-1-phosphates when reacted with GTP, affording the corresponding sugar-nucleotides 
in yields between 30-85% on multi-milligram scales. Given the unusual substrate promiscuity 
observed for manC, a truncated mutation was created to investigate the role of the C-terminal 
domain in overall enzyme activity and substrate specificity. The mutant accepted its natural 
substrates Man 1-phosphate and GTP, but exhibited 100-fold lower GDP-mannose 
pyrophosphorylase activity and no longer accepted other NTPs or sugar-1-phosphates, 
suggesting the C-terminal domain was crucial for the observed substrate promiscuity.  
 
  
 
 
 
 
Scheme 16. Sugar-nucleotide synthesis catalysed by manC from Pyrococcus furiosus. 
 
3.3. Emergent enzymes for sugar-nucleotide synthesis 
 
GT catalysed reactions are known to be readily reversible and highly substrate 
dependent. The majority of GTs are Leloir (sugar-nucleotide dependent) enzymes and consume 
NDP-sugars as donors for glycoside bond formation to an aglycone partner. This renders the 
reverse reaction, to form a sugar-nucleotide, thermodynamically unfavourable. In 2011, 
Thorson and co-workers reported a landmark discovery for the use of activated sugar donors 
that could dramatically and favourably shift the equilibrium of a GT-catalysed reaction towards 
sugar-nucleotide formation.45 In order to overcome the thermodynamic barrier, activated sugar 
donors, aromatic O-glycosides, were used to alter the equilibrium position of an inverting 
macrolide-inactivating glycosyltransferase mutant, OleD, variant TDP-16 (Scheme 17a). 2-
chloro-4-nitrophenyl β-D-glucopyranoside was optimised as the donor from a screen of 32 
putative glycosyl donors. 
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The OleD mutant was shown to catalyse the formation of UDP-Glc and TDP-Glc in 
good yield (55% and 61% respectively) using a 1:1 molar ratio of UDP or TDP to glycoside 
donor and on a representative scale (6-7mg). ΔG°pH8.5 for the reaction was calculated at -2.78 
kcal mol-1, notably exothermic and corresponding to a dramatic shift in Keq, favouring sugar-
nucleotide formation. An important observation was that donor hydrolysis was not a 
detrimental competing reaction. A wider evaluation of the Glc-donor component revealed 
OleD TDP-16 to tolerate deoxygenation at C2, C3, C4 or C6, C3 epimerization and an array 
of substitution at C6 (SH, N3, Hal), providing an impressive access to 22 natural and non-
natural T/UDP-sugars. The group proceeded to use their sugar-nucleotide forming platform for 
single and dual GT coupled reactions, alongside a colourimetric screen for NDP-sugar 
formation (provided by the phenolate by-product of the GT reaction), opening access to 
glycoconjugates derived from sugar-nucleotide donors.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 17. a) Activated aromatic activated glucopyranosides for sugar-nucleotide formation with GT mutant 
OleD, from Streptomyces antibioticus b) OleD Loki catalysed transglycosylation reactions of 2-chloro-4-
nitrophenyl glucosamino/xylosamino donors to afford 4-methylumbelliferone glucosamino-/xylosaminosides. 
The workers have recently expanded the capability of their GT mutant, evolving the 
OleD sequence to an OleD Loki variant, capable of recognising six uniquely functionalised 
sugar donors and five structurally different NDP acceptors, broadening the scope of the process 
further to 30 distinct sugar-nucleotides.46 OleD Loki has also been used to access aminosugar-
nucleotides, which serve as important structural building blocks for a range of 
glycoconjugates.47 The mutant enzyme converted 12 of 14 aminosugar glycosyl donors to the 
target T/UDP-aminosugars and, despite showing overall preference for glucosides, also 
accepted non-native donors such as Glc-6-NAc (Scheme 17b). The OleD Loki system was also 
able to mediate glycosylation of a model acceptor, fluorescent 4-methylumbelliferone, 
permitting coupled transglycosylation processes and a series of model 4-methylumbelliferone 
glucosamino-/xylosaminosides were produced (Scheme 17b).  
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UDP-Xyl acts as the donor substrate for xylosylation of different acceptor molecules, 
typified by proteoglycan biosynthesis where it transferred to a protein acceptor by a 
xylosyltransferase (XylT). Access to this sugar-nucleotide is vital for the study of XylTs from 
the perspective of inhibitor strategies and the functional cell biology of the enzyme. In 2014, 
Nidetzky reported an in vitro one-pot synthesis of UDP-Xyl using UPD-Glc as a donor 
substrate via an oxidative decarboxylation process (Scheme 18).48 A two-step conversion of 
UDP-Glc to UDP-Xyl via UDP-GlcUA was catalysed by UDP-glucose dehydrogenase 
(hUGDH) and UDP-xylose synthase (hUXS). hUGDH was coupled to a NAD+ coenzyme 
regeneration cascade using a xylose reductase (CtXR) and bovine liver catalase.  
NAD+ was regenerated by reduction of 9,10-phenanthrenequinone (PQ) with CtXR, 
affording 9,10-phenantheren hydroquinone (PQH2), which was spontaneously re-oxidised by 
molecular oxygen, supplied in situ by periodic feeding with H2O2. Moreover, the reduction of 
molecular oxygen provided a strong thermodynamic driving force for the cycle. The workers 
optimised an efficient one pot, two-step system as they initially observed that a one pot, one-
step process produced UDP-Xyl which inhibited hUGDH, retarding the efficiency of the 
system. Henceforth, they first converted UDP-Glc to UDP-GlcA, optimising the reaction 
parameters to 37 °C and pH 7.5, which were amenable to the second hUXS step. Their approach 
enabled production of 19.5 mM (10.5 g L-1) of UDP-Xyl which, after a two-step 
chromatographic purification, was obtained in high purity (>98%) and good overall yield (5.3 
mg, 46%). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 19. Synthesis of UDP-Xyl via chemoenzymatic redox cascade through the combined action of human 
hUGDH, hUXS, CtXR from Candidia tenuis and bovine catalase.  
 
The results provide a strong case for application of multi-step redox cascades in the 
synthesis of sugar-nucleotides as both the enzymes utilised exhibit no observable back reaction, 
which presents a clear advantage in having eliminated the thermodynamic restrictions of 
nucleotidyltransferase catalysed conversions or the need for the thermodynamic pull of a 
pyrophosphatase. 
Recently, an in-microbe methodology to produce normal and labelled NDP-sugars has 
been developed by Bar-Peled and colleagues,49 who demonstrated the use of E. coli, 
metabolically engineered, to contain genes that encode proteins to convert monosaccharides 
into their respective monosaccharide-1-phosphates and subsequently into the corresponding 
sugar-nucleotide shown to yield 5 to 12.5 microg/ml cell culture. This presents an alternative 
method from classical in vitro chemoenzymatic synthesis and OPME processes. 
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 5. Summary and Outlook 
 
 Since 2009 there have been considerable developments in enzymatic methods to access 
sugar-nucleotides. Broadly speaking, pyrophosphorylases dominate for the formation of UDP, 
GDP and dTDP systems, however, the advent of the OleD GT system has now extended this 
classification. Additionally, the volume of structure-activity data that now exists for these 
enzymes regarding their capability to accept and process non-native substrates is impressive 
and ever expanding. This is vital to the relevance of these sugar-nucleotide tools to interrogate 
biological glycosylation processes. Coupled to this are ever improving analytical capabilities 
for multi-enzyme cascade reactions, evidenced most recently by Elling’s multiplexed capillary 
electrophoresis (MP-CE), a fast analytical tool for the optimisation of sugar-nucleotide 
synthesis using multi-enzyme cascade reactions.50 
Combined with these enzymatic capabilities is the contributions of chemical synthesis 
for modification of both the glycosyl 1-phosphate and nucleotide components and the 
symbiosis of these two approaches will ensure that that the field of sugar-nucleotide synthesis 
continues to prosper.  
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